Form F-10 - Registration Statement for Securities of certain Canadian Issuers.:
SEC Accession No. 0000912282-12-000543
Filing Date
2012-06-21
Accepted
2012-06-21 16:49:18
Documents
6

Document Format Files

Seq Description Document Type Size
1 oncolytics_f10-june2012.htm F-10 321605
2 ex5_1.htm EX-5.1 5643
3 ex5_2.htm EX-5.2 5409
4 oncolytics_logo.jpg GRAPHIC 12620
5 reovirus.jpg GRAPHIC 86821
6 onco_corpstructure.jpg GRAPHIC 21489
  Complete submission text file 0000912282-12-000543.txt   500638
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10 | Act: 33 | File No.: 333-182260 | Film No.: 12920209
SIC: 2834 Pharmaceutical Preparations